Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3) Peptid
SART3
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle SART3 Produkte
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SART3 antibody (Catalog #: ARP39128_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3) peptide
SART3 Reaktivität: Human Wirt: Synthetic BP, Imm
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
- Synonyme
- SART3 Peptide, DKFZp469J2418 Peptide, si:ch211-191d15.4 Peptide, wu:fc51h03 Peptide, DSAP1 Peptide, P100 Peptide, RP11-13G14 Peptide, TIP110 Peptide, p110 Peptide, p110(nrb) Peptide, AU045857 Peptide, mKIAA0156 Peptide, squamous cell carcinoma antigen recognized by T-cells 3 Peptide, squamous cell carcinoma antigen recognized by T-cells 3 L homeolog Peptide, squamous cell carcinoma antigen recognized by T cells 3 Peptide, SART3 Peptide, sart3 Peptide, sart3.L Peptide, Sart3 Peptide
- Hintergrund
-
SART3 is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. SART3 is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This protein is thought to be involved in the regulation of mRNA splicing.
Alias Symbols: P100, p110, DSAP1, TIP110, p110(nrb), RP11-13G14
Protein Interaction Partner: AR,COIL,MEGF10,PRPF3,RNPS1,AR,C3orf17,C3orf26,CDK9,DDX47,FRG1,LSM2,LSM4,LSM6,LSM7,MEPCE,MLF1IP,NAA38,PPIH,PRPF3,PRPF31,PRPF4,RNPS1,RPF2,RRP15,SNRPB,SRBD1,TUT1,USP15,USP39,USP4
Protein Size: 364 - Molekulargewicht
- 40 kDa
- Gen-ID
- 9733
- NCBI Accession
- NM_014706
-
Sie sind hier:
